Bipolar Androgen Therapy (BAT) and Radium-223 (RAD) in Metastatic Castration-resistant Prostate Cancer (mCRPC)
Last updated on July 2021Recruitment
- Recruitment Status
- Not yet recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Castration Resistant
- Metastatic Prostate Adenocarcinoma
- Prostate Adenocarcinoma
- Type
- Interventional
- Phase
- Phase 2
- Design
- Allocation: N/AIntervention Model: Single Group AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Only males
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT04704505
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Pedro Isaacsson Velho, M,D Moinhos de Vento Hospital Principal Investigator: Samuel Denmeade, M,D Sidney Kimmel Comprehensive Cancer Center at the Johns Hopkins Hospital